Related Experiment Video
Updated: Nov 12, 2025

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
Published on: April 12, 2024
Quantitative assessment of HCC wash-out on CT is a predictor of early complete response to TACE
Marco Fronda1, Andrea Doriguzzi Breatta1, Marco Gatti2
1Department of Surgical Sciences - Radiology Unit, A.O.U. Città della Salute e della Scienza di Torino, Via Genova 3, 10126, Turin, Italy.
Insights
Quantitative assessment of wash-out on preprocedural CT scans predicts early complete response to drug-eluting-bead transarterial chemoembolization (DEB-TACE) for HCC. The delayed percentage attenuation ratio (DPAR) shows the best predictive ability for treatment success.
Area of Science:
- Hepatocellular Carcinoma (HCC) research
- Interventional Radiology
- Medical Imaging Analysis
Background:
- Drug-eluting-bead transarterial chemoembolization (DEB-TACE) is a primary treatment for hepatocellular carcinoma (HCC).
- Predicting early treatment response is crucial for optimizing patient management and outcomes.
- Four-phase contrast-enhanced CT (CECT) is a standard imaging modality for HCC evaluation.
Purpose of the Study:
- To evaluate the predictive value of preprocedural four-phase CECT for early complete response (CR) to DEB-TACE in HCC.
- To specifically assess the role of quantitative wash-in and wash-out parameters in predicting CR.
- To identify the most effective quantitative metric for predicting DEB-TACE outcomes.
Main Methods:
- Retrospective analysis of 129 HCC nodules treated with first-line DEB-TACE.
- Quantitative analysis of preprocedural CECT including contrast enhancement ratio (CER), lesion-to-liver contrast ratio (LLC), absolute wash-out (WOabs), relative wash-out (WOrel), and delayed percentage attenuation ratio (DPAR).
- Early radiological response assessed by mRECIST criteria, dichotomized into CR versus other responses.
Main Results:
- All wash-out variables (WOabs, WOrel, DPAR) were significantly higher in lesions achieving CR.
- DPAR demonstrated the best discriminating ability (AUC = 0.80) for predicting CR.
- DPAR ≥ 120 was associated with an odds ratio of 3.3 for CR (p = 0.0026).
- DPAR ≥ 120 combined with smooth lesion margins yielded a 78% CR rate.
- Quantitative wash-in estimates (CER, LLC) did not show a significant association with CR.
Conclusions:
- Quantitative assessment of HCC wash-out on preprocedural CECT is a valuable predictor of early CR following DEB-TACE.
- DPAR is the most effective quantitative metric for predicting treatment response among the evaluated wash-out formulas.
- Combining DPAR ≥ 120 with smooth lesion margins identifies patients with a high likelihood of achieving CR.
Objectives:
To investigate the predictive value of four-phase contrast-enhanced CT (CECT) for early complete response (CR) to drug-eluting-bead transarterial chemoembolization (DEB-TACE), with a particular focus on the quantitatively assessed wash-in and wash-out.
Methods:
A retrospective analysis of preprocedural CECTs was performed for 129 HCC nodules consecutively subjected to DEB-TACE as first-line therapy. Lesion size, location, and margins were recorded. For the quantitative analysis, the following parameters were computed: contrast enhancement ratio (CER) and lesion-to-liver contrast ratio (LLC) as estimates of wash-in; absolute and relative wash-out (WOabs and WOrel) and delayed percentage attenuation ratio (DPAR) as estimates of wash-out. The early radiological response of each lesion was assessed by the mRECIST criteria and dichotomized in CR versus others (partial response, stable disease, and progressive disease).
Results:
All quantitatively assessed wash-out variables had significantly higher rates for CR lesions (WOabs p = 0.01, WOrel p = 0.01, and DPAR p = 0.00002). However, only DPAR demonstrated an acceptable discriminating ability, quantified by AUC = 0.80 (95% CI0.73-0.88). In particular, nodules with DPAR ≥ 120 showed an odds ratio of 3.3(1.5-7.2) for CR (p = 0.0026). When accompanied by smooth lesion margins, DPAR ≥ 120 lesions showed a 78% CR rate at first follow-up imaging. No significative association with CR was found for quantitative wash-in estimates (CER and LLC).
Conclusions:
Based on preprocedural CECT, the quantitative assessment of HCC wash-out is useful in predicting early CR after DEB-TACE. Among the different formulas for wash-out quantification, DPAR has the best discriminating ability. When associated, DPAR ≥ 120 and smooth lesion margins are related to relatively high CR rates.
Key Points:
• A high wash-out rate, quantitatively assessed during preprocedural four-phase contrast-enhanced CT (CECT), is a favorable predictor for early radiological complete response of HCC to drug-eluting-bead chemoembolization (DEB-TACE). • The arterial phase of CECT shows great dispersion of attenuation values among different lesions, even when a standardized protocol is used, limiting its usefulness for quantitative analyses. • Among the different formulas used to quantify the wash-out rate (absolute wash-out, relative wash-out, and delayed percentage attenuation ratio), the latter (DPAR), based only on the delayed phase, is the most predictive (AUC = 0.80), showing a significant association with complete response for values above 120.
More Related Videos
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
09:49Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization
Published on: December 2, 2013